Assay Report Card

Basic Information

ID: ALA4479000

Type: ADME

Description: Drug activation in human Hep3B cells assessed as human CYP3A4-mediated drug metabolism-induced cytotoxicity measured as decrease in cell viability at 300 uM pre-incubated with BSO for 18 hrs followed by incubation with compound for 3 hrs in presence of NADPH measured after 24 hrs in absence of compound, CYP3A4 and NADPH by cell titer-glo luminescence assay relative to BSO alone

Organism: Homo sapiens

Activity Charts

Compound Summary

Parent Molecular WeightALogPPolar Surface Area
331.351.581.58
267.371.611.61
180.161.311.31
416.361.891.89
330.751.891.89
253.281.371.37
331.183.753.75
385.512.092.09
375.874.434.43
266.302.652.65
76.05-0.96-0.96
137.14-0.31-0.31
182.190.070.07
319.884.814.81
261.091.881.88
276.751.741.74
274.803.823.82
399.442.872.87
236.273.393.39
144.212.292.29
560.690.920.92
179.262.032.03
238.332.852.85
352.772.812.81
244.263.683.68
242.703.063.06
123.110.780.78
613.802.872.87
356.453.163.16
281.362.842.84
123.11-0.42-0.42
287.363.383.38
267.24-0.20-0.20
331.471.321.32
230.102.362.36
151.251.911.91
229.26-0.59-0.59
239.311.311.31
167.200.600.60
198.310.740.74
295.381.531.53
211.261.131.13
270.351.781.78
454.450.270.27
230.263.043.04
246.31-0.28-0.28
408.522.342.34
211.22-0.50-0.50
218.260.540.54
204.31-0.29-0.29
1449.27
249.10-1.27-1.27
1202.63
239.753.303.30
720.965.915.91
551.634.204.20
270.213.253.25
224.22-0.71-0.71
261.091.881.88
334.172.892.89
365.410.020.02
378.433.523.52
118.16-0.22-0.22
337.464.504.50
424.532.442.44
153.140.670.67
301.734.344.34
312.411.291.29
249.273.603.60
242.273.673.67
273.242.552.55
495.756.886.88
286.341.091.09
484.50-7.29-7.29
152.180.640.64
822.954.344.34
255.23-1.97-1.97
225.21-1.33-1.33
457.480.190.19
236.23-0.21-0.21
308.333.613.61
136.110.060.06
217.290.630.63
289.381.931.93
441.40-0.04-0.04
244.21-3.01-3.01
780.952.222.22
1000.341.791.79
581.58-8.16-8.16
226.23-0.05-0.05